Stephanie B. Mounaud is a senior scientific project analyst in the Therapeutic Development Branch within NCATS’ Division of Preclinical Innovation, where she assists senior program and project managers in the Therapeutics for Rare and Neglected Diseases program. Mounaud also supports the division’s role in the Helping to End Addiction Long-termSM Initiative, or NIH HEAL InitiativeSM. In this capacity, Mounaud supports and helps manage the early discovery and preclinical drug development phases through investigational new drug submission and, in some cases, early clinical development.
Prior to joining NCATS in January 2021, Mounaud was a scientific project manager at the J. Craig Venter Institute for more than 14 years, during which she served as a laboratory manager in the infectious disease department and as a member of the microbial genome finishing team. Mounaud also was involved with several education and science, technology, engineering and mathematics (STEM) outreach activities, as well as professional development training for graduate-level and postgraduate-level participants. She also served as the president of the Biosciences, Health Science and Medicine Program Advisory Committee for the Montgomery County Collaboration Board.
Mounaud earned her Bachelor of Science in microbiology, minoring in chemistry and French, from Virginia Tech. She also is a certified Project Management Professional (PMP)®.
Mounaud’s research interests include the infant nasopharyngeal microbiome, Burkholderia genetics and mycology. Her recent work focused on small-colony variants in Burkholderia persisters populations. Mounaud’s previous work included studying secondary metabolites from fungus as potential bacterial quorum, sensing inhibitors and studying the pediatric nasopharyngeal microbiome with the goal of identifying associations among infants and known risk factors, including the pneumococcal vaccination status.